Kintara Therapeutics Inc (KTRA)

[imrichbeotch]

Moving nicely. Wonder if they have any prospects?

[retiredtech]

Thanks dino for the info. I did not know about the warrant strike prices.

[dinogreeves]

Did you know, they have warrant strike prices one at 26 and the other one at 62, which will fund them 21 million dollars, they are there for a reason although the years are a little ahead, between I believe 2024-2026.?

[QuantumTravesty]

Decent webcast this time,, https://wsw.com/webcast/rhk2/ktra/1608222

[HJ72]

https://www.otcmarkets.com/filing/html?id=16242678&guid=2aG-kKevTCFAB3h

[retiredtech]

Yep, they are going after money/investors. Had to have it.

[QuantumTravesty]

Corporate Presentation December 2022 https://www.sec.gov/Archives/edgar/data/1498382/000149315222034417/ex99-1.htm

[HJ72]

Yes they are, I’m very excited to be holding this!

[dinogreeves]

This is going to blow the top off very soon. Just think of the pipeline the stage and the FDA fast track designation, market cap where it and where it needs to be. Do not dwell over this at all, this is destined to hit a market cap of 75-100 million, just with those, not to mention a partnership most probably has been or being hammered out, what if a scenario of a buyout, Oh Lord 500 million dollar!!!! Could catapult this stock overnight to 400 dollars minimum buyout price of 500 million dollars, what if big Pharma sees massive potential with this science and the price tag is 2 billion dollars. Hold on to your seats this is going to be massive.

[retiredtech]

Looks like these guys are onto something. They are going to go down in history for their life saving efforts.

[HJ72]

https://oncologytube.com/article/41446/val-083-dennis-brown-2022-key-facts-to-consider-glioblastoma-1?channelName=Cancernewsupdate

[HJ72]

VAL-083 news will be explosive.

[dinogreeves]

I am still here, holding to every and each single share, not going to get shaken out, market makers are dancing around on level 2 as watching the beautiful scenery, there is huge spread at times with this, that in itself shows that this could run, just got to hold, there is not much downside with 10 million market cap biotech with a 2/3 phase in metastatic breast cancer, which got the FDA fast track, I strongly believe they haven't filed for an offering for a reason, very possible they are hammering out the deal with a partnership. 1.5 million float and low OS, only way is up North. This is prepping and being marinated for a huge run, I give it 2 weeks we should be at $20.00, if there are no huge surprises. They could even sell the company for minuscule of 500 million dollars, just think about the stock price at that point.

[retiredtech]

The PPS will rise again. There are NO shares to short so the NAKED SHORTS will HAVE TO cover the same day or pay for the shares. Would not want to be naked shorting this stock.

[imrichbeotch]

I agree with you there. I brought a decent lot on the ask just to see what would happen and the price dropped.

[retiredtech]

There are NO shares to short so the MM's just drag the PPS down, even on buys, to depress the rise. This will change next week when we get word of financing in place for the last trial.

[imrichbeotch]

You got to love this blatant manipulation.

[imrichbeotch]

Yep. Looking at level 2 they dancing around like mofos

[retiredtech]

These MM's on this stock ARE A CROOKED AS A BARREL OF SNAKES. Manipulation is really, really bad.

[retiredtech]

There are ONLY 3 people in this company. They set the company up TO BE BOUGHT. We will hear something the week of the 5th after the conference. BIG MONEY investors are there just looking for good investments. This product has an 80% efficacy rating which is SUPER GOOD and why FDA fast tracked this cure.

[imrichbeotch]

Yea if the data is good big pharma will snatch them up. I still can’t believe they only have almost 2 million shares. This thing has the potential to explode

[HJ72]

https://www.stocktitan.net/news/KTRA/kintara-therapeutics-to-participate-at-the-rhk-capital-disruptive-6lyv9gqyx8fz.html

Not just one but TWO late stage phase 3 ready programs with FDA approval for fast track with a 1.6 m OS.
Their data is better then big pharma.

[retiredtech]

Totally correct: "I wouldn't be surprised they already have somebody lined up. 12 million market cap for a phase 2/3 breast cancer, FDA fast track designation, will propel this stock. "
This PPS will skyrocket when they get financing to perform phase 2/3 trials.

[dinogreeves]

Under these circumstances after a huge reverse split, Biotechs come back with an offering, that has been the norm, strangely enough no filings, no self offering of some sort yet, that tells me, this company is aiming for a partnership at some point, the tale of the tape the story, they definitely don't want this sub $10.00, I will this is going to breakout fairly soon and I wouldn't be surprised they already have somebody lined up. 12 million market cap for a phase 2/3 breast cancer, FDA fast track designation, will propel this stock. Have a feeling this is the SAV*A.

[retiredtech]

MM's are controlling the PPS really tight, but, it will explode once they let it go. I see $20 to $30 dollars. Once this drug gets approved this PPS will be over $100.

[imrichbeotch]

Man if that’s true with such a small float omg this bad boy can explode

[dinogreeves]

10,000 shares at 5.80 average. This could be the next IND*O.

[retiredtech]

Major NAKED SHORTING on this stock. Hey SEC, DO YOUR JOB and make them STOP THIS CHIT.

[retiredtech]

MM's holding the PPS in tight loop from 6.17 to 6.39. A-holes ALL OF THEM.

[retiredtech]

Market Makers are trying desperately to hold this PPS down.

[retiredtech]

NO shares available to short which means that there is a ton of NAKED SHORTING going on.

[QuantumTravesty]

When the price of a stock is changing, impacting its prices by 10% or more within five minutes, it is a situation when a stock halt scenario gets triggered, and an exchange can put a halt to its trading.

[QuantumTravesty]

Rather predictable huh? 10/30/22 Kintara Therapeutics's (NASDAQ:KTRA) short percent of float has risen 4894.88% since its last report. The company recently reported that it has 2.04 million shares sold short, which is 126.87% of all regular shares that are available for trading. Based on its trading volume, it would take traders 0.9 days to cover their short positions on average.

[retiredtech]

Trading resumed at 9:38A. Still no answer as to why halt.

[retiredtech]

Trading Halted at 9:34A. I think buyers outran the float. We will see.

[retiredtech]

ONLY 1.5M float. Really, really thin at $5.08. Double dollars coming.

[QuantumTravesty]

Yup it would not have lost 25% from $0.10 if it dropped to otc and another 50% in a few weeks at most like it probably will starting Monday.

[blackcat]

I still say they should have let it go OTC, It's in a worse place now.

[QuantumTravesty]

Well pre-split shares have essentially met my call of going to zero and it’s know untouchable post split while the short sellers masacre it down from $3.50-$4 when it opens Monday. The only thing to do now is buy it after any positive news that causes it to go higher and miss the first pop because it’s speculatively radioactive now to enter.

[INFINITI]

Hmmmmm

[Invest-in-America]

KTRA: Up HUGE in the 'Pre-Market' behind THAT kind ambiguous, negative, "NEWS" today????? WHAT????

[kzivann]

Premarket action on news trail being paused to save $$$.

KTRA

[QuantumTravesty]

Yes it would be the best short term for current shareholders from a fiduciary aspect imo too but I figure ceo types egos and looking forward to obtaining financing, partner investors and eventually “product success” they will burn through replaceable stock to maintain the prestige listing. With no large block outside institutional ownership to influence decisions it’s at the mercy of the bod’s.
Once shareholders are this far underwater they vote for whatever lifeline is thrown their way.

[blackcat]

I brought that up a couple months ago. I'd be fine with a drop to OTC. I'd buy my shares back in a hot minute.

[QuantumTravesty]

Somebody on stocktwits posted this fwiw. Be interesting if they dropped to otc and avoided r/s and Nasdaq listing fees.
Orensova
57m
$KTRA hi, fellow investors I would like to share that I just finished a 30min zoom call with the CEO Mr.Hofman.
So, first of all, he is a great guy and seems to work in many directions for the company and the shareholders.
He believes that they are one of the only treatments left standing in the GCAR trails. He is reducing the cash burn rate to about 1M $ a month and has well enough for 1st Q 23 and will need about 9-10m$ to reach the finish line for GCAR results. there are risks and r/s may be in the cards, but also OTC is not a wrong place to rebuild since Inst are not in a habit to invest in 10 cents stocks.
I got a lot of confidence after talking to him (by the way, there is no 136m$ debt for the company as was misunderstood by another board. Its an accumulated loss). I will not sell my shares and will also add. Good luck to him and his staff and also to us.
There is a light at the end of this tunnel.

[Maknmoney78]

Did someone on this board say that kintara therapeutics was basically in their back yard? I can’t remember who had messaged me that

[QuantumTravesty]

So far no! Only lower lows. Looks like it’s going to stay here until earnings and then get punished like a red head stepchild.

[blackcat]

Are we sure this stock actually has a bottom other than $0.00?

[QuantumTravesty]

rsi 30.89 @ $0.141 is either a bounce or a break lower. I figure it’s going lower but not under $0.10 yet lol.

[QuantumTravesty]

Lol yes I think you’re right.